Ahmed, M. A., Starrett, J., Hoffman, I., Nelson, K., Neal, M., Pache, M., Pettitt, E., Bensen, D., Hudkins, R., Harris, T., Swanson, R. (2025). TYRA-430: First reversible FGFR4/3 inhibitor designed to overcome current challenges in FGF19-driven hepatocellular carcinoma treatment.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.583